series-a
Stage
1
Investors
About
Develops therapeutics that write or modify genetic information to treat disease. Described by the investor as focused on "curing disease by writing in the code of life."
Explore Tessera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.